Magnesium acethyltaurate as a potential agent for retinal and optic nerve protection in glaucoma  

作　　者：Igor Iezhitsa Renu Agarwal 

机构地区：[1]Centre for Neuroscience Research, Faculty of Medicine, Universiti Teknologi MARA [2]Volgograd State Medical University, Research Institute of Pharmacology

出　　处：《Neural Regeneration Research》2018年第5期807-808,共2页中国神经再生研究（英文版）

基　　金：supported by Institut Pengurusan Penyelidikan(RMI);Universiti Teknologi MARA,Malaysia,under the grant No.600-IRMI/MyRA 5/3/LESTARI(0088/2016)and 600-IRMI/DANA 5/3/LESTARI(0076/2016)

摘　　要：Glaucoma is the second leading cause of irreversible vision impairment affecting more than 70 million people worldwide with approximately 10%suffering from glaucoma-related bilateral blind（Quigley and Broman,2006）.It is a multi-factorial disease that is characterized by optic nerve damage and visual field loss.Progressive loss of retinal ganglion cells（RGCs）resulting in visual field deficits is the hallmark of glaucoma.Glaucoma is the second leading cause of irreversible vision impairment affecting more than 70 million people worldwide with approximately 10%suffering from glaucoma-related bilateral blind（Quigley and Broman,2006）.It is a multi-factorial disease that is characterized by optic nerve damage and visual field loss.Progressive loss of retinal ganglion cells（RGCs）resulting in visual field deficits is the hallmark of glaucoma.

关 键 词：Magnesium acethyltaurate as a potential agent for retinal and optic nerve protection in glaucoma 

分 类 号：R775[医药卫生—眼科]